Cite

HARVARD Citation

    Franco, R. et al. (2022). The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases. Expert opinion on therapeutic targets. pp. 791-800. [Online]. 
  
Back to record